Vaccination and induction of autoimmune diseases
M Bereau - Inflammation & Allergy-Drug Targets (Formerly …, 2015 - ingentaconnect.com
Vaccines have been suspected of playing a role in inducing autoimmune disease (AID) for
a long time. However, apart from certain specific vaccine strains and complications (such as …
a long time. However, apart from certain specific vaccine strains and complications (such as …
Robot-induced hallucinations in Parkinson's disease depend on altered sensorimotor processing in fronto-temporal network
…, J Horvath, M Franza, S Konik, M Bereau… - Science Translational …, 2021 - science.org
Hallucinations in Parkinson’s disease (PD) are disturbing and frequent non-motor
symptoms and constitute a major risk factor for psychosis and dementia. We report a robotics-based …
symptoms and constitute a major risk factor for psychosis and dementia. We report a robotics-based …
Clinico‐Genetic, Imaging and Molecular Delineation of COQ8A‐Ataxia: A Multicenter Study of 59 Patients
…, P De Jonghe, W De Ridder, M Bereau… - Annals of …, 2020 - Wiley Online Library
Objective To foster trial‐readiness of coenzyme Q8A (COQ8A)‐ataxia, we map the clinicogenetic,
molecular, and neuroimaging spectrum of COQ8A‐ataxia in a large worldwide cohort, …
molecular, and neuroimaging spectrum of COQ8A‐ataxia in a large worldwide cohort, …
[HTML][HTML] Apathy in Parkinson's disease: Clinical patterns and neurobiological basis
Apathy is commonly defined as a loss of motivation leading to a reduction in goal-directed
behaviors. This multidimensional syndrome, which includes cognitive, emotional and …
behaviors. This multidimensional syndrome, which includes cognitive, emotional and …
Impact of subthalamic deep brain stimulation on impulse control disorders in Parkinson's disease: a prospective study
…, A Vrillon, E Hainque, M Béreau… - Movement …, 2021 - Wiley Online Library
… Mathieu Béreau reports reimbursement of travel expenses to scientific meetings from Elivie,
Medtronic, and Boston Scientific and honoraria from Merz Pharma and Allergan for lecturing, …
Medtronic, and Boston Scientific and honoraria from Merz Pharma and Allergan for lecturing, …
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: a retrospective multicentric study
…, C Papeix, H Zephir, M Bereau… - Multiple Sclerosis …, 2020 - journals.sagepub.com
Objectives: We aim to (1) determine the frequency and distinctive features of short myelitis (SM)
and longitudinally extensive transverse myelitis (LETM) in a cohort of adults with myelin …
and longitudinally extensive transverse myelitis (LETM) in a cohort of adults with myelin …
Increased diagnostic yield in complex dystonia through exome sequencing
…, MA Spitz, V Laugel, M Bereau… - Parkinsonism & Related …, 2020 - Elsevier
Introduction A strategy based on targeted gene panel sequencing identifies possibly
pathogenic variants in fewer than 20% of cases in early-onset and familial form of dystonia. By …
pathogenic variants in fewer than 20% of cases in early-onset and familial form of dystonia. By …
Freezing of gait and its levodopa paradox
J Nonnekes, M Bereau, BR Bloem - JAMA neurology, 2020 - jamanetwork.com
Freezing of gait (FOG) in Parkinson disease (PD) is common and disabling. It has 3
phenotypes, 1 the least common one being akinetic freezing (a lack of discernible leg …
phenotypes, 1 the least common one being akinetic freezing (a lack of discernible leg …
A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study
M Fabbri, C Leung, G Baille, M Béreau… - Parkinsonism & Related …, 2021 - Elsevier
Background In 2020 the coronavirus disease 19 (COVID-19) pandemic imposed a total and
sudden lockdown. We aimed to investigate the consequences of the first COVID-19 …
sudden lockdown. We aimed to investigate the consequences of the first COVID-19 …
[HTML][HTML] Overview on wearable sensors for the management of Parkinson's disease
…, E Roze, D Devos, G Dupont, M Bereau… - npj Parkinson's …, 2023 - nature.com
Parkinson’s disease (PD) is affecting about 1.2 million patients in Europe with a prevalence
that is expected to have an exponential increment, in the next decades. This epidemiological …
that is expected to have an exponential increment, in the next decades. This epidemiological …